Ximluci, a Lucentis Biosimilar, Launches in Europe

Partners STADA Arzneimittel and Xbrane Biopharma have launched Ximluci, a ranibizumab biosimilar, in several European countries for the treatment of several ophthalmic conditions. Partners STADA Arzneimittel and Xbrane Biopharma have launched Ximluci, a ranibizumab biosimilar, in several European